Clinical Trial Update: AG-013736 In Combination With Gemcitabine Versus Gemcitabine Alone For Patients With Metastatic Pancreatic Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating AG-013736 plus gemcitabine versus gemcitabine alone in metastatic pancreatic cancer has completed with results posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Neoplasms

Drugs mentioned

• AG-013736
• Gemcitabine (Gemcitabine)

Snippet

Sponsor: Pfizer | Conditions: Pancreatic Neoplasms | Phase 2 | Status: COMPLETED | Results posted: 2012-08-24